• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清自分泌运动因子与重度肥胖女性的肝脂肪变性独立相关。

Serum autotaxin is independently associated with hepatic steatosis in women with severe obesity.

作者信息

Rachakonda Vikrant P, Reeves Valerie L, Aljammal Jules, Wills Rachel C, Trybula Joy S, DeLany James P, Kienesberger Petra C, Kershaw Erin E

机构信息

Division of Gastroenterology, Department of Medicine, University of Pittsburgh, Pennsylvania, USA; Division of Endocrinology, Department of Medicine, University of Pittsburgh, Pennsylvania, USA.

出版信息

Obesity (Silver Spring). 2015 May;23(5):965-72. doi: 10.1002/oby.20960. Epub 2015 Apr 10.

DOI:10.1002/oby.20960
PMID:25865747
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4414671/
Abstract

OBJECTIVE

Autotaxin (ATX) is an adipocyte-derived lysophospholipase that generates the lipid signaling molecule lysophosphatidic acid (LPA). The aim of this study was to determine the relationship between serum ATX and nonalcoholic fatty liver disease (NAFLD) in females with obesity.

METHODS

101 nondiabetic women with obesity (age: 31.5-55.8 years; BMI: 35.0-64.5 kg/m2) were classified as having NAFLD (36.3%) or not having NAFLD (63.7%) based on the degree of hepatic steatosis on abdominal CT. Subjects were characterized for metabolic phenotype including measures of energy, glucose, and lipid homeostasis. Fasting serum adipokines and inflammatory markers were determined by ELISA. Linear regression analysis was used to determine features independently associated with NAFLD.

RESULTS

Subjects with and without NAFLD differed in several key features of metabolic phenotype including BMI, waist circumference, fasting glucose and insulin, HOMA-IR, VLDL, triglycerides, and ALT. Serum adipokines, including ATX and leptin, were higher in subjects with NAFLD. Serum ATX was significantly correlated with alkaline phosphatase, fasting glucose, fasting insulin, and HOMA-IR. Linear regression analysis revealed that serum triglycerides and log-transformed ATX were independently associated with hepatic steatosis.

CONCLUSIONS

Serum ATX may be a potential pathogenic factor and/or biomarker for NAFLD in nondiabetic women with obesity.

摘要

目的

自分泌运动因子(ATX)是一种源自脂肪细胞的溶血磷脂酶,可生成脂质信号分子溶血磷脂酸(LPA)。本研究旨在确定肥胖女性血清ATX与非酒精性脂肪性肝病(NAFLD)之间的关系。

方法

101名非糖尿病肥胖女性(年龄:31.5 - 55.8岁;BMI:35.0 - 64.5 kg/m²)根据腹部CT上肝脏脂肪变性程度分为患有NAFLD(36.3%)或未患有NAFLD(63.7%)。对受试者的代谢表型进行特征分析,包括能量、葡萄糖和脂质稳态指标。通过酶联免疫吸附测定法测定空腹血清脂肪因子和炎症标志物。采用线性回归分析确定与NAFLD独立相关的特征。

结果

患有和未患有NAFLD的受试者在代谢表型的几个关键特征上存在差异,包括BMI、腰围、空腹血糖和胰岛素、HOMA-IR、极低密度脂蛋白、甘油三酯和谷丙转氨酶。包括ATX和瘦素在内的血清脂肪因子在患有NAFLD的受试者中较高。血清ATX与碱性磷酸酶、空腹血糖、空腹胰岛素和HOMA-IR显著相关。线性回归分析显示,血清甘油三酯和经对数转换的ATX与肝脏脂肪变性独立相关。

结论

血清ATX可能是肥胖非糖尿病女性NAFLD的潜在致病因素和/或生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/561e/4414671/fba68955a4d5/nihms-636179-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/561e/4414671/5b03a169c7a1/nihms-636179-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/561e/4414671/c05b3917a177/nihms-636179-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/561e/4414671/fba68955a4d5/nihms-636179-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/561e/4414671/5b03a169c7a1/nihms-636179-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/561e/4414671/c05b3917a177/nihms-636179-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/561e/4414671/fba68955a4d5/nihms-636179-f0003.jpg

相似文献

1
Serum autotaxin is independently associated with hepatic steatosis in women with severe obesity.血清自分泌运动因子与重度肥胖女性的肝脂肪变性独立相关。
Obesity (Silver Spring). 2015 May;23(5):965-72. doi: 10.1002/oby.20960. Epub 2015 Apr 10.
2
Serum Autotaxin/ENPP2 correlates with insulin resistance in older humans with obesity.血清自分泌运动因子/胞外核苷酸焦磷酸酶/磷酸二酯酶2与老年肥胖人群的胰岛素抵抗相关。
Obesity (Silver Spring). 2015 Dec;23(12):2371-6. doi: 10.1002/oby.21232. Epub 2015 Nov 2.
3
Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease.血清自分泌运动因子水平与非酒精性脂肪性肝病患者的肝纤维化和气球样变相关。
World J Gastroenterol. 2018 Mar 21;24(11):1239-1249. doi: 10.3748/wjg.v24.i11.1239.
4
Gender Specific Association of Serum Leptin and Insulinemic Indices with Nonalcoholic Fatty Liver Disease in Prediabetic Subjects.糖尿病前期患者血清瘦素和胰岛素指标与非酒精性脂肪性肝病的性别特异性关联
PLoS One. 2015 Nov 16;10(11):e0142165. doi: 10.1371/journal.pone.0142165. eCollection 2015.
5
Serum AFBP levels are elevated in patients with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者的血清AFBP水平升高。
Scand J Gastroenterol. 2014 Aug;49(8):979-85. doi: 10.3109/00365521.2013.836754. Epub 2014 Jun 24.
6
Serum Osteocalcin Levels in Children With Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病患儿的血清骨钙素水平
J Pediatr Gastroenterol Nutr. 2018 Jan;66(1):117-121. doi: 10.1097/MPG.0000000000001768.
7
Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.肥胖和代谢综合征作为通过超声诊断的非酒精性脂肪性肝病发生的风险因素。
Vojnosanit Pregl. 2016 Oct;73(10):910-20. doi: 10.2298/VSP150514093P.
8
Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.非酒精性脂肪性肝病与代谢综合征的关联独立于中心性肥胖和胰岛素抵抗。
Sci Rep. 2016 Jun 1;6:27034. doi: 10.1038/srep27034.
9
Serum C1q/TNF-related protein 9 is not related to nonalcoholic fatty liver disease.血清 C1q/TNF 相关蛋白 9 与非酒精性脂肪性肝病无关。
Cytokine. 2018 Oct;110:52-57. doi: 10.1016/j.cyto.2018.04.019. Epub 2018 Apr 25.
10
Insulin resistance, but not insulin response, during oral glucose tolerance test (OGTT) is associated to worse histological outcome in obese NAFLD.口服葡萄糖耐量试验(OGTT)期间的胰岛素抵抗,但不是胰岛素反应,与肥胖非酒精性脂肪性肝病(NAFLD)的更差组织学结果相关。
Nutr Metab Cardiovasc Dis. 2020 Jan 3;30(1):106-113. doi: 10.1016/j.numecd.2019.08.001. Epub 2019 Aug 10.

引用本文的文献

1
Regulatory role of S1P and its receptors in sepsis-induced liver injury.1-磷酸鞘氨醇(S1P)及其受体在脓毒症诱导的肝损伤中的调节作用。
Front Immunol. 2025 Jan 28;16:1489015. doi: 10.3389/fimmu.2025.1489015. eCollection 2025.
2
Plasma Lysophosphatidic Acid Concentrations in Sex Differences and Psychiatric Comorbidity in Patients with Cocaine Use Disorder.血浆溶血磷脂酸浓度在可卡因使用障碍患者的性别差异和精神共病中的作用。
Int J Mol Sci. 2023 Oct 25;24(21):15586. doi: 10.3390/ijms242115586.
3
Effects of a 12-week whole-grain or refined wheat intervention on plasma acylcarnitines, bile acids and signaling lipids, and association with liver fat: A metabolomics study of a randomized controlled trial.

本文引用的文献

1
ENPP2 contributes to adipose tissue expansion and insulin resistance in diet-induced obesity.ENPP2 促进饮食诱导肥胖中的脂肪组织扩张和胰岛素抵抗。
Diabetes. 2014 Dec;63(12):4154-64. doi: 10.2337/db13-1694. Epub 2014 Jun 26.
2
Involvement of autotaxin/lysophosphatidic acid signaling in obesity and impaired glucose homeostasis.自分泌酶/溶血磷脂酸信号通路在肥胖及葡萄糖稳态受损中的作用。
Biochimie. 2014 Jan;96:140-3. doi: 10.1016/j.biochi.2013.04.010. Epub 2013 Apr 29.
3
Lysophosphatidic acid impairs glucose homeostasis and inhibits insulin secretion in high-fat diet obese mice.
一项为期12周的全谷物或精制小麦干预对血浆酰基肉碱、胆汁酸和信号脂质的影响及其与肝脏脂肪的关联:一项随机对照试验的代谢组学研究
Front Nutr. 2022 Oct 13;9:1026213. doi: 10.3389/fnut.2022.1026213. eCollection 2022.
4
Hepatocyte-Secreted Autotaxin Exacerbates Nonalcoholic Fatty Liver Disease Through Autocrine Inhibition of the PPARα/FGF21 Axis.肝细胞分泌的自分泌酶通过自分泌抑制 PPARα/FGF21 轴加剧非酒精性脂肪性肝病。
Cell Mol Gastroenterol Hepatol. 2022;14(5):1003-1023. doi: 10.1016/j.jcmgh.2022.07.012. Epub 2022 Aug 2.
5
Red Blood Cell-Conditioned Media from Non-Alcoholic Fatty Liver Disease Patients Contain Increased MCP1 and Induce TNF-α Release.非酒精性脂肪性肝病患者的红细胞条件培养基中MCP1含量增加并诱导TNF-α释放。
Rep Biochem Mol Biol. 2022 Apr;11(1):54-62. doi: 10.52547/rbmb.11.1.54.
6
Autotaxin-LPA-LPP3 Axis in Energy Metabolism and Metabolic Disease.自分泌酶-LPA-LPP3 轴在能量代谢和代谢性疾病中的作用。
Int J Mol Sci. 2021 Sep 3;22(17):9575. doi: 10.3390/ijms22179575.
7
The ZJU index is a powerful surrogate marker for NAFLD in severely obese North American women.ZJU 指数是北美肥胖女性非酒精性脂肪性肝病的有力替代标志物。
PLoS One. 2019 Nov 26;14(11):e0224942. doi: 10.1371/journal.pone.0224942. eCollection 2019.
8
Elevated Autotaxin and LPA Levels During Chronic Viral Hepatitis and Hepatocellular Carcinoma Associate with Systemic Immune Activation.慢性病毒性肝炎和肝细胞癌期间自分泌运动因子和溶血磷脂酸水平升高与全身免疫激活相关。
Cancers (Basel). 2019 Nov 25;11(12):1867. doi: 10.3390/cancers11121867.
9
The Novel Perspectives of Adipokines on Brain Health.脂肪因子对大脑健康的新视角。
Int J Mol Sci. 2019 Nov 11;20(22):5638. doi: 10.3390/ijms20225638.
10
Deregulated Lysophosphatidic Acid Metabolism and Signaling in Liver Cancer.肝癌中溶血磷脂酸代谢与信号传导的失调
Cancers (Basel). 2019 Oct 23;11(11):1626. doi: 10.3390/cancers11111626.
溶血磷脂酸损害高脂饮食肥胖小鼠的葡萄糖稳态并抑制胰岛素分泌。
Diabetologia. 2013 Jun;56(6):1394-402. doi: 10.1007/s00125-013-2891-3. Epub 2013 Mar 19.
4
Autotaxin in liver fibrosis.自分泌酶在肝纤维化中的作用。
Clin Chim Acta. 2012 Nov 20;413(23-24):1817-21. doi: 10.1016/j.cca.2012.07.014. Epub 2012 Jul 20.
5
Depot-specific regulation of autotaxin with obesity in human adipose tissue.肥胖症患者脂肪组织中自动分泌酶的储存特异性调节。
J Physiol Biochem. 2012 Dec;68(4):635-44. doi: 10.1007/s13105-012-0181-z. Epub 2012 May 27.
6
Adipose-specific disruption of autotaxin enhances nutritional fattening and reduces plasma lysophosphatidic acid.脂肪特异性敲除自分泌运动因子可增强营养性肥胖,并降低血浆溶血磷脂酸。
J Lipid Res. 2011 Jun;52(6):1247-1255. doi: 10.1194/jlr.M014985. Epub 2011 Mar 18.
7
Non-contrasted computed tomography for the accurate measurement of liver steatosis in obese patients.非对比计算机断层扫描在肥胖患者肝脂肪变性的精确测量中的应用。
Dig Dis Sci. 2011 Jul;56(7):2145-51. doi: 10.1007/s10620-011-1602-5. Epub 2011 Feb 12.
8
Effects of diet and physical activity interventions on weight loss and cardiometabolic risk factors in severely obese adults: a randomized trial.饮食和身体活动干预对重度肥胖成年人减肥和心血管代谢风险因素的影响:一项随机试验。
JAMA. 2010 Oct 27;304(16):1795-802. doi: 10.1001/jama.2010.1505. Epub 2010 Oct 9.
9
Autotaxin--an LPA producing enzyme with diverse functions.自分泌酶--一种具有多种功能的 LPA 产生酶。
J Biochem. 2010 Jul;148(1):13-24. doi: 10.1093/jb/mvq052. Epub 2010 May 21.
10
Adipokines in liver diseases.肝脏疾病中的脂肪因子
Hepatology. 2009 Sep;50(3):957-69. doi: 10.1002/hep.23046.